A Study to Learn About the Safety of Taking an Additional Dose of the Medicine Rimegepant in Adults With Migraine
Abroad (travel likely)RecruitingPHASE4
Conditions
Acute Treatment of Migraine
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Hope Clinical Research, Canoga Park, California, United States
Neurology Offices of South Florida, Boca Raton, Florida, United States
Brainstorm Research, Miami, Florida, United States
Clinical Neuroscience Solutions, Orlando, Florida, United States
New England Regional Headache Center, Worcester, Massachusetts, United States
Michigan Headache & Neurological Institute, Ann Arbor, Michigan, United States
FutureSearch Trials of Dallas, Dallas, Texas, United States
Study leads
Pfizer CT.gov Call Center
Study Director
Pfizer